2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2024-03-30 |
|
2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2024-03-30 ±³À°ÁÖÁ¦ : 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿ò ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ ´ã´çÀÚ : ±èÈñ¿µ À̸ÞÀÏ : stroke@stroke.or.kr ±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú Âü¼®¿¹»óÀÎ : 100¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 0¿ø ºñ°í
±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:00~09:20 Interpretation of long-term monitoring in ESUS patients Á¤¿äÇÑ(¿¬¼¼ÀÇ´ë ½Å°æ°ú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:20~09:50 ESUS Case series - cardiologist view Â÷¸íÁø(¿ï»êÀÇ´ë ½ÉÀå³»°ú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:50~10:05 ESUS Case series - neurologist view °¹Î°æ(ÀÌÈÀÇ´ë½Å°æ°ú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:05~10:20 Clinical Implications of Atrial Fibrillation Detection Using Wearable Devices in Patients With Cryptogenic Stroke (CANDLE-AF) Trial results of inter-rim analysis ¼ÛÅÂÁø(ÀÌÈÀÇ´ë ½Å°æ°ú) Åä·Ð 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:20~10:30 Discussion ( ) ÈÞ½Ä 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:30~10:50 Coffee Break ( ) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:50~11:10 Transthoracic echocardiography for stroke patients ¹ÚÀçÇü(Ãæ³²ÀÇ´ë ¼øȯ±â³»°ú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:10~11:30 Transesophageal Echocardiography for stroke patients ¹è´ëȯ(ÃæºÏÀÇ´ë ¼øȯ±â³»°ú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:30~11:50 Cardiac MRI ÀüÀºÁÖ(¼¿ïÀÇ´ë ¿µ»óÀÇÇаú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:50~12:10 Cardiac CT Ȳ¼ºÈ£(°í·ÁÀÇ´ë ¿µ»óÀÇÇаú) Åä·Ð 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:10~12:30 Discussion ( ) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:30~13:30 CHAT GPT in research ¹ÚÇüÁØ(¿ï»êÀÇ´ë Á¤º¸ÀÇÇаú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:30~13:50 Stroke-heart syndrome: Underlying mechanism and clinical manifestation Á¤Áø¸¸(°í·ÁÀÇ´ë ½Å°æ°ú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:50~14:20 Stroke-heart syndrome: Recent advance and current challenges ¾È¼ºÈ£(ºÎ»êÀÇ´ë ½Å°æ°ú) Åä·Ð 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:20~14:30 Discussion ( ) ÈÞ½Ä 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:30~14:50 Coffee Break ( ) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:50~15:10 Work up of ESUS considering lesion pattern ±è¹üÁØ(¼¿ïÀÇ´ë ½Å°æ°ú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:10~15:30 ESUS patient results with ROS-ESUS data ¼¿ì±Ù(¼º±Õ°üÀÇ´ë ½Å°æ°ú) ±³À°½Ã°£ 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:30~15:50 ILR vs 7day-monitoring ±è¹üÁØ(¿ï»êÀÇ´ë ½Å°æ°ú) Åä·Ð 03¿ù 30ÀÏ »ï¼º¼¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:50~16:20 Discussion ( )
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 825 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 765 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 771 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 627 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 992 , ´ñ±Û¼ö : 0 |